# Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis

> **NCT00997438** · PHASE1 · COMPLETED · sponsor: **Portland VA Medical Center** · enrollment: 69 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Lipoic Acid

## Key facts

- **NCT ID:** NCT00997438
- **Lead sponsor:** Portland VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997438, "Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00997438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*